Journal Mobile Options
Table of Contents
Vol. 47, No. 1, 1999
Issue release date: January 1999

Bilateral Oophorectomy in Asymptomatic Women over 50 Years Old Selected by Ovarian Cancer Screening

Hayashi H. · Yaginuma Y. · Kitamura S. · Saitou Y. · Miyamoto T. · Komori H. · Wada K. · Ishikawa M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The purpose of this study was to evaluate bilateral oophorectomy in women over 50 years old found to have an adnexal mass using transvaginal ultrasonography (TVS) as a mass screening. With TVS a total of 23,451 women without symptoms were examined for ovarian cancer at annual screening for uterine cervical cancer. Two hundred fifty-eight women over 50 years old persistently had abnormal TVS results and 95 women gave informed consent for surgical tumor removal. In the 95 women operated, 7 malignant ovarian cancers were found. Especially adnexal masses which were thought to be benign were treated by laparoscopic surgery.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Dembo AJ, Day M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K: Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:2363–273.
  2. Boring CC, Squires TS, Tong T: Cancer statistics 1992. CA Cancer J Clin 1992;42:19–38.
  3. Barber HR, Graber EA: The PMPO syndrome (postmenopausal palpable ovary syndrome. Obstet Gynecol 1971;38:921–923.

    External Resources

  4. Rulin MC, Preston AL: Adnexal masses in postmenopausal women. Obstet Gynecol 1987;70:578–581.

    External Resources

  5. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, Miller A, Park R, Major F Jr: Adjuvant therapy in stage I and II epithelial ovarian cancer: Results of two prospective randomized trial. N Engl J Med 1990;322:1021–1027.
  6. Recuss ML, Kolton S, Tharakan T: Transvaginal ultrasonography in gynecologic office practice: Assessment in 663 premenopausal women. Am J Obstet Gynecol 1996;175:1189–1194.
  7. Bourne TH, Whitehead MI, Campbell S, Royston P, Bhan V, Collins WP: Ultrasound screening for familial ovarian cancer. Gynecol Oncol 1991;43:92–97.
  8. Campbell S, Bhan V, Royston P, Whitehead M, Collins W: Transabdominal ultrasound screening for early ovarian cancer. BMJ 1989;299:1363–1367.

    External Resources

  9. Van Nagell JR Jr, Depriest PD, Puls LE, Donaldson ES, Gallion HH, Pavlik EJ, Powell DE, Kryscio RJ: Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Cancer 1991;68:458–462.
  10. Van Nagell JR Jr, Gallion HH, Pavlik JE, DePriest DP: Ovarian cancer screening. Cancer 1995;76(suppl 10):2086–2091.
  11. Rock AJ, Thompson DJ: TeLinde’s Operative Gynecology, ed 8. Philadelphia, Lippincott-Raven, 1997.
  12. Granberg S, Wikland M: A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in group of women at risk for ovarian cancer. J Ultrasound Med 1988;7:59–64.

    External Resources

  13. Rulin MC, Preston AL: Adnexal masses in postmenopausal women. Obstet Gynecol 1987;70:578–581.

    External Resources

  14. Hall D, McCarthy K: The significance of the postmenopausal simple adnexal cyst. J Ultrasound Med 1986;5:503–505.

    External Resources

  15. Einhorn N, Bast R, Knapp RC, Tjernberg B, Zurawski VR Jr: Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 1986;67:414–416.

    External Resources

  16. Gadducci A, Ferdcghini M, Prontera C, Moretti L, Mariani G, Bianchi R, Fioretti P: The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis. Gynecol Oncol 1992;44:147–154.
  17. Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S: CA 125 in gynecological pathology – A review. Eur J Obstet Gynecol Reprod Biol 1993;49:115–124.
  18. Jacobs I, Davies AP, Bridges J, Stabile I, Fay T, Lower A, Grudzinskas JG, Oram D: Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. BMJ 1993;306:1030–1034.
  19. Stenback F: Benign, borderline and malignant serous cystadenomas of the ovary. Pathol Res Pract 1981;172:58–72.

    External Resources

  20. Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, van Nagell JR Jr: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol 1992;47:53–57.
  21. Barber HRK: Prophylaxis in ovarian cancer. Cancer 1993;71(suppl 4:)1529–1533.
  22. Grundsell H, Ekman G, Gullberg B, Johnsson JE, Larsson G, Lindahl B, Moller T, Trope C: Some aspects of prophylactic oophorectomy and ovarian carcinoma. Ann Chir Gynaecol 1981;70:36–42.

    External Resources

  23. Orlando R, Lirussi F, Nassuato G, Okolicsanyi L: Complications of laparoscopy in the elderly: A report on 345 consecutive cases and comparison with younger population. Endoscopy 1987;19:145–146.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50